Like you, we at LILIUM want our lives to get back to normal as quickly as possible. Our goal is to eliminate the SARS-CoV-2 virus as quickly as possible.
Due to the high level of contagiousness of SARS-CoV-2, scientists predict that a 95% efficacious vaccine would require up to 80% of the entire population to be fully vaccinated. As SARS-CoV-2 continues to mutate, it is likely to become more contagious, which would result in this 80% target to go up as well.
More and more experts believe that vaccinations alone aren’t going to get the SARS-CoV-2 virus under control. In previous pandemics, vaccines have taken years or decades to eliminate a contagious disease from a nation. Mask wearing and social distancing may be the norm for years to come, unless another solution can be depolyed.
Current Covid vaccines reduce the chances of hospitalizations and death from Covid. However, the vaccines are not 100% effective. They also do not eliminate the chance of getting infected with SARS-CoV-2 and infecting others with the virus. Since the vaccines are so new, long term side-effects of the vaccines are not yet known, and new short term side-effects are still being discovered. However, the benefits of mass vaccination is expected to outweigh the risks of doing nothing.
Unfortunately new variants of concern reduce the effectiveness of vaccines and natural immunity. Booster shots can help to increase immunity but also the risk of unknown long term side-effects. Due to a lack of vaccine manufacturing capacity and much of the world still not vaccinated, new variants of concern are likely to continue emerging creating a vicious cycle of requiring more and more vaccines. Ultimately new experimental vaccines with their own unknown side-effects may be needed if new variants of concern erode the efficacy of the current vaccines.
Lilium’s Covid screening platform can rapidly identify SARS-CoV-2 and variants of concern before an infected person has much of a chance of infecting anyone else. Combined with its high accuracy, this means that an infected person may be made aware of their status early enough in the infection cycle to enable them to isolate before infecting anyone else. Due to the mass scale of the Lilium platform, an entire community, city or even a country can be rapidly tested at the same time, cornering the virus and eliminating its transmission regardless of which variant it is.
Viral load calculations and growth rates enabled by the Lilium platform may also allow medical professionals to make more informed decisions on any treatment strategies that may benefit infected individuals, that could reduce the risk of death or ending up in the ICU.
Importantly testing is safe and has no side-effects.
Using LILIUM’s convenient but highly accurate mass testing platform would allow individuals who are asymptomatic or pre-symptomatic to learn about their infection early and isolate before they have a chance to transmit the virus. This would reduce the number of new infections enormously, allowing us to keep our community safe together.
A strategy that pairs LILIUM’s cutting edge testing system with highly effective vaccines will empower businesses, institutions, and individuals to keep the SARS-CoV-2 virus under control, so life can get back to normal.